Literature DB >> 23288652

A note from history: landmarks in history of cancer, part 5.

Steven I Hajdu1, Farbod Darvishian.   

Abstract

In the 3 decades from 1910 to 1940, more progress took place in cancer research and the diagnosis and treatment of cancers than during the prior centuries combined. The discovery of several carcinogens, precancerous conditions, and hereditary cancers adduced new thoughts about the genesis of cancers. Even though diagnostic radiology and radiation therapy became apposite specialties, surgery retained its primacy in the treatment of cancer patients. The delineation of new and distinct neoplastic entities, several precancerous lesions, and noninvasive carcinomas as well as the introduction of histopathologic grading of cancers promulgated cogent changes in therapy. Yet, with all the advances in the diagnosis and treatment of cancers, very little betterment could be demonstrated in the overall survival of patients, and by the end of the 1930s, cancer became the second most common cause of death in the United States.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2013        PMID: 23288652     DOI: 10.1002/cncr.27889

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Peptide Hydrogels - Versatile Matrices for 3D Cell Culture in Cancer Medicine.

Authors:  Peter Worthington; Darrin J Pochan; Sigrid A Langhans
Journal:  Front Oncol       Date:  2015-04-20       Impact factor: 6.244

2.  Antibody Therapeutics in Oncology.

Authors:  Erik D Wold; Vaughn V Smider; Brunhilde H Felding
Journal:  Immunotherapy (Los Angel)       Date:  2016-02-01

Review 3.  Current Developments of N-Heterocyclic Carbene Au(I)/Au(III) Complexes toward Cancer Treatment.

Authors:  Alexia Tialiou; Jiamin Chin; Bernhard K Keppler; Michael R Reithofer
Journal:  Biomedicines       Date:  2022-06-15

Review 4.  Albert C. Broders, tumor grading, and the origin of the long road to personalized cancer care.

Authors:  James R Wright
Journal:  Cancer Med       Date:  2020-05-07       Impact factor: 4.452

5.  Ernst von Leyden (1832-1910): a pioneer in making oncology a respected medical discipline.

Authors:  Peter Voswinckel; Nils Hansson
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-21       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.